TechCrunch Startup News

The European startup market is ready for the limelight

The region's startup market is hungry for its first trillion-dollar startup, and in many ways has set itself up to reach that goal. Learn more about your ad choices. Visit podcastchoices.com/adchoices [https://podcastchoices.com/adchoices]

Source: Kalshi’s valuation jumps to $11B after raising massive $1B round ; plus, this startup can track objects within 3 cm

The quickly growing prediction betting market raised fresh capital from Sequoia and CapitalG, according to someone familiar with the deal. Also, Point One Navigation, now valued at $230 million, is building out well beyond automotive. Learn more about your ad choices. Visit podcastchoices.com/adchoices [https://podcastchoices.com/adchoices]

After SEC investigation, Curastory founder resigns, hires replacement

Curastory’s founder and CEO, Tiffany Kelly, has resigned from the role and replaced herself with Dave Dickman, former CEO of the influencer marketing platform Tagger. Learn more about your ad choices. Visit podcastchoices.com/adchoices [https://podcastchoices.com/adchoices]

Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation

When Anthony Sardain began developing Cavela in 2023, an AI startup that helps brands automate supplier sourcing, he did not foresee that new tariffs would drive customers to become increasingly wary of manufacturing products in China. Function Health, which offers a regular lab testing service to help people track their health, wants to change that by consolidating health data and making it usable for its customers by connecting that data to an AI model. To further that effort, the company recently raised $298 million in a Series B round led by Redpoint Ventures at a valuation of $2.5 billion. Learn more about your ad choices. Visit podcastchoices.com/adchoices [https://podcastchoices.com/adchoices]

Onepot AI raises $13M to help make chemical drug creation easier

“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is the creation of new molecules by using chemical reactions. It’s like a recipe or Lego pieces, where small pieces, ingredients, molecules, come together to form a wider puzzle picture, a food dish, a larger molecule. Learn more about your ad choices. Visit podcastchoices.com/adchoices [https://podcastchoices.com/adchoices]